Mobile technology in the management of allergic rhinitis
Publication in refereed journal


Full Text

Other information
AbstractAllergic rhinitis (AR) is a common chronic disease that significantly affects the quality of life of individuals and their families. AR also has a significant effect on work productivity, days off work and absence from school, resulting in a significant burden on society. Guideline-based treatment algorithms are readily available, in particular the Allergic Rhinitis and its impact on Asthma (ARIA) guidelines which are widely publicized1 (Fig. 1). Despite the availability of these guidelines, treatment of AR remains inadequate for many patients due to a variety of reasons, including the lack of well-defined characterization of AR control, accurate stratification of patients, patient adherence to therapy, patient understanding of the disease and healthcare professional care provision.2,3
An important aspect that is often overlooked is a patient’s expectations and understanding of their own disease process. Patients seek effective treatments that can control all their symptoms resulting from AR, but they also hope for a rapid relief of symptoms when using their medications which does not necessarily occur. Additionally, they may feel that their healthcare providers do not take their symptoms seriously nor understand their AR treatment needs. These factors may lead to patient dissatisfaction and non-adherence to their prescribed therapies.4 To address these issues, a possible solution is to encourage patients to understand and take control of their own disease, so that they will inform healthcare providers of the nature of their disease to direct treatment. The mobile technology is a potential platform to help drive this process.
All Author(s) ListCHAN Jason Ying Kuen
Journal nameHong Kong Institute of Allergy Newsletter
Year2018
Month10
Issue NumberOct 2018
PublisherHong Kong Institute of Allergy
Pages16 - 18
LanguagesEnglish-United States
KeywordsAllergic rhinitis

Last updated on 2019-24-01 at 12:10